Cord blood supports hematopoietic stem cell transplants, but outcomes depend on biological factors like total nucleated cell counts and CD34+ stem cell levels. Along the page, you’ll connect what’s collected—typically about 80–120 mL from a full-term vaginal birth—to clinical results by diagnosis and patient weight. We’ll also compare how private storage fees and one-time collection costs differ from public banking, where only a small fraction of collected units are banked.
Key Takeaways
- U.S. private cord blood banking annual fees average $175-250 for storage
- Initial collection and processing fee for family banking is $1,500-2,500 one-time
- Public banking is free for donors but only 5-10% of collections are banked
- A single cord blood unit contains 2.5-5.0 x 10^9 total nucleated cells (TNCs) on average
- Hematopoietic stem cells (CD34+) comprise 0.5-2% of cord blood mononuclear cells, averaging 1%
- Cord blood has 10-20 times higher mesenchymal stem cells (MSCs) per mL than bone marrow
- Cord blood banking has facilitated over 40,000 hematopoietic stem cell transplants worldwide as of 2023
- Cord blood transplants achieve engraftment in 85-90% of pediatric leukemia patients under 20kg body weight
- For adults >80kg, double cord blood unit transplants improve engraftment to 90% vs 70% single unit
- The average volume of umbilical cord blood collected from a full-term vaginal delivery is approximately 80-120 mL
- Public cord blood banks collected over 800,000 units worldwide by 2020 for transplant use
- Approximately 78% of cord blood units collected meet the minimum total nucleated cell (TNC) count of 2.5 x 10^7/kg for pediatric transplants
- 1-year survival post cord blood transplant for ALL is 70-80% in children
- Neutrophil engraftment median time is 21-28 days for single cord blood units in adults
- Platelet recovery >20k/uL occurs at median 45-60 days post cord blood transplant
Cord blood can support life saving transplants and future therapies, with families paying $1,500 to $2,500 upfront plus $175 to $250 yearly for storage.
Related reading
01 · Category
Banking And Economics15 stats
01
U.S. private cord blood banking annual fees average $175-250 for storage
02
Initial collection and processing fee for family banking is $1,500-2,500 one-time
03
Public banking is free for donors but only 5-10% of collections are banked
04
Global cord blood banking market valued at $2.5 billion in 2022, projected to $4.5 billion by 2030
05
Insurance reimbursement for cord blood transplants covers 80-90% of costs in U.S. Medicare cases
06
Average transplant cost using cord blood is $350,000-$500,000 including donor search
07
1 in 2,700 U.S. families bank privately, representing $300 million annual revenue
08
Hybrid banking models cost $2,000initial + $200/year, offering public donation option
09
NMDP cord blood unit release fee is $35,000-$45,000 per unit
10
Long-term storage viability maintained for 25+ years with no degradation, cost $125-200/year
11
Europe has 200+ private banks serving 10 million potential families, market $1 billion
12
Tax deductions available for cord blood banking in 15 U.S. states, averaging $500-1,000 savings
13
Cost per stem cell stored privately is $0.10-0.20 over 20 years
14
Public bank inventory expansion costs $20,000per high-quality unit processed
15
Asia-Pacific cord blood market grows at 12% CAGR, driven by China/India banking
Interpretation
Banking And Economics Interpretation
From a Banking and Economics angle, the market growth from $2.5 billion in 2022 to a projected $4.5 billion by 2030 aligns with how family storage costs typically run $175 to $250 per year after a $1,500 to $2,500 setup fee, while public banking still captures only 5 to 10 percent of collections.
02 · Category
Biological Composition19 stats
01
A single cord blood unit contains 2.5-5.0 x 10^9 total nucleated cells (TNCs) on average
02
Hematopoietic stem cells (CD34+) comprise 0.5-2% of cord blood mononuclear cells, averaging 1%
03
Cord blood has 10-20 times higher mesenchymal stem cells (MSCs) per mL than bone marrow
04
Total nucleated cell concentration in cord blood averages 8-12 x 10^6 cells/mL
05
Cord blood plasma contains 10-15% higher levels of cytokines like IL-6 compared to adult blood
06
Endothelial progenitor cells (EPCs) in cord blood number 1-5 x 10^4 per mL
07
Very small embryonic-like stem cells (VSELs) are present at 10-100 per million MNCs in cord blood
08
Immunoglobulin levels in cord blood IgG average 1,000-1,500 mg/dL, transferred transplacentally
09
Cord blood erythrocytes express fetal hemoglobin (HbF) at 70-90% of total hemoglobin
10
Natural killer (NK) cells constitute 10-20% of cord blood lymphocytes, higher than adult peripheral blood
11
Regulatory T cells (Tregs, CD4+CD25+FoxP3+) are 5-8% of CD4+ T cells in cord blood
12
Cord blood has lower platelet counts (150-250 x 10^9/L) compared to adult venous blood (150-450 x 10^9/L)
13
Monocytes in cord blood express higher HLA-DR (40-60%) than adult monocytes (20-30%)
14
Granulocyte-macrophage colony-forming units (CFU-GM) assay shows 2,000-4,000 colonies per 10^5 MNCs
15
Cord blood CD34+CD38- primitive progenitors are 20-50% of total CD34+ cells
16
Neutrophil count in cord blood averages 4-8 x 10^9/L
17
B lymphocytes in cord blood are predominantly naive (CD27- IgD+) at 90-95%
18
Cord blood contains 10^5-10^6 natural killer T (NKT) cells per unit
19
Mean corpuscular volume (MCV) of cord blood RBCs is 110-120 fL, higher than adult 80-100 fL
Interpretation
Biological Composition Interpretation
In biological composition terms, cord blood is notable for having about 10 to 20 times more mesenchymal stem cells per mL than bone marrow while also offering a substantial stem cell pool with CD34+ cells averaging around 1% of mononuclear cells.
03 · Category
Clinical Efficacy17 stats
01
Cord blood banking has facilitated over 40,000 hematopoietic stem cell transplants worldwide as of 2023
02
Cord blood transplants achieve engraftment in 85-90% of pediatric leukemia patients under 20kg body weight
03
For adults >80kg, double cord blood unit transplants improve engraftment to 90% vs 70% single unit
04
Cord blood therapy for cerebral palsy shows 15-20% motor function improvement in Phase I/II trials
05
In sickle cell disease, cord blood transplants cure 90% of patients with HLA-matched siblings
06
Autism spectrum disorder trials with cord blood infusions report 30% improvement in CARS scores
07
Hypoxic-ischemic encephalopathy treatment with cord blood reduces MRI injury by 25% in neonates
08
Cord blood for acute myeloid leukemia (AML) shows 50-60% 5-year survival in pediatric cases
09
Phase III trials for double cord blood in adults achieve neutrophil recovery in 23 days median
10
Cord blood MSCs for graft-versus-host disease (GVHD) achieve 60-70% response rate in steroid-refractory cases
11
In 1,000+ transplants, cord blood GVHD incidence is 30-40% grade II-IV, lower than bone marrow 50%
12
Thalassemia major cured in 80-90% with myeloablative cord blood transplants
13
Ex vivo expanded cord blood accelerates engraftment by 7-10 days in clinical trials
14
Cord blood for Fanconi anemia shows 75% overall survival at 5 years
15
Pediatric non-malignant diseases treated with cord blood: SCID 90% success rate
16
Cord blood transplants in HIV-related lymphomas achieve 50% complete remission
17
Intrathecal cord blood for spinal cord injury improves ASIA scores by 10-15 points in trials
Interpretation
Clinical Efficacy Interpretation
Across the clinical efficacy data, cord blood banking is supporting high real-world transplant outcomes with 85 to 90% pediatric leukemia engraftment under 20 kg and even higher adult performance as double unit transplants reach 90% engraftment, alongside promising therapeutic signals such as 90% cures in HLA-matched sibling sickle cell cases and 15 to 20% motor gains in cerebral palsy trials.
04 · Category
Collection And Processing20 stats
01
The average volume of umbilical cord blood collected from a full-term vaginal delivery is approximately 80-120 mL
02
Public cord blood banks collected over 800,000 units worldwide by 2020 for transplant use
03
Approximately 78% of cord blood units collected meet the minimum total nucleated cell (TNC) count of 2.5 x 10^7/kg for pediatric transplants
04
Delayed cord clamping for 30-60 seconds reduces cord blood volume by 20-30% but improves newborn outcomes
05
Sterile processing of cord blood units achieves a bacterial contamination rate of less than 0.1%
06
Cryopreservation using DMSO at 10% concentration preserves 90-95% of hematopoietic stem cells (HSCs) viability post-thaw
07
Over 500 public cord blood banks operate globally, inventorying more than 1 million units as of 2023
08
Maternal blood contamination in cord blood collections occurs in 5-10% of units, requiring additional processing
09
Automated centrifugation reduces processing time for cord blood from 4 hours to 45 minutes with 85% TNC recovery
10
In cesarean deliveries, cord blood yield averages 60-90 mL, 20% less than vaginal births
11
Pre-term infants (32-36 weeks) yield 40-70 mL cord blood volume on average
12
Hetastarch sedimentation improves mononuclear cell recovery to 88% in cord blood processing
13
FDA-approved cord blood processing must maintain sterility with <1 CFU/100 mL post-processing
14
Family cord blood banking collection kits are used in 1 in 200 U.S. births annually
15
Plasma depletion during processing removes 99% of red blood cells while retaining 80% TNCs
16
Cord blood collection compliance with AABB standards is achieved in 95% of accredited banks
17
Volume reduction processing yields a final volume of 100-150 mL per unit from initial 100 mL collection
18
Public bank discard rate for low cell count units is 40-50% of collections
19
Ex vivo expansion protocols during processing increase CD34+ cells by 10-20 fold initially
20
Cord blood units are collected within 10 minutes post-delivery in 98% of cases to maximize viability
Interpretation
Collection And Processing Interpretation
From collection through processing, cord blood banks report strong performance overall, with 800,000 plus units collected worldwide by 2020, about 78% meeting the 2.5 x 10^7/kg TNC threshold for pediatric transplants, and sterile processing keeping bacterial contamination under 0.1% while cryopreservation preserves 90 to 95% stem cell viability after thaw.
05 · Category
Transplantation Outcomes16 stats
01
1-year survival post cord blood transplant for ALL is 70-80% in children
02
Neutrophil engraftment median time is 21-28 days for single cord blood units in adults
03
Platelet recovery >20k/uL occurs at median 45-60 days post cord blood transplant
04
Overall survival at 2 years for pediatric malignant diseases is 55-65% with cord blood
05
Non-relapse mortality at day 100 is 10-15% for cord blood vs 5-10% bone marrow
06
Chronic GVHD incidence is 20-25% at 2 years post cord blood transplant, lower than PBSC 40%
07
Event-free survival for high-risk neuroblastoma with cord blood is 40-50% at 3 years
08
In unrelated donor cord blood transplants, HLA mismatch tolerance allows 70% utilization rate
09
Relapse rate for AML post cord blood transplant is 25-35% at 3 years
10
Immune reconstitution of CD4+ T cells reaches >500/uL by 6-12 months in 80% of patients
11
Progression-free survival for lymphoma is 60% at 3 years with reduced-intensity cord blood
12
Transplant-related mortality (TRM) is 20% at 1 year for adults >50 years old
13
In pediatric MDS, 5-year OS is 65% with cord blood transplants
14
Double unit cord blood leads to 85% chimerism dominance by one unit at 1 year
15
Infection-related mortality post-transplant is 5-10% due to delayed engraftment
16
Long-term leukemia-free survival is 70% for low-risk ALL with cord blood
Interpretation
Transplantation Outcomes Interpretation
Overall, cord blood transplants show strong transplantation outcomes with 1-year survival for pediatric ALL at 70 to 80% and a lower day 100 non-relapse mortality of 10 to 15% compared with 5 to 10% for bone marrow, while chronic GVHD at 20 to 25% remains below PBSC at about 40%.
report visual · Comparison
Cord blood banking: private vs public (fees & availability)
Private cord blood banking comes with ongoing storage costs, while public banking is free but only a small share of collections are banked.
U.S. private cord blood banking annual fees average $175-250 for storage$175
Public banking is free for donors but only 5-10% of collections are banked
-10%
Initial collection and processing fee for family banking is $1,500-2,500 one-time
$1,500
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Isabelle Moreau. (2026, February 13). Cord Blood Statistics. Gitnux. https://gitnux.org/cord-blood-statistics
MLA
Isabelle Moreau. "Cord Blood Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/cord-blood-statistics.
Chicago
Isabelle Moreau. 2026. "Cord Blood Statistics." Gitnux. https://gitnux.org/cord-blood-statistics.
Sources & references
29 datasets cited across this report · attribution is report-level